Cosco International, Inc.
FDA inspection history in Marietta, Georgia, 2020 to 2025
- 2
- Warning letters
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2020: one warning letter; 2024: one Form 483; 2025: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2020One warning letter.
- 2024–25One Form 483 and one warning letter, at Marietta, Georgia.
Cited most
Across all Cosco International observations on file
- 21 CFR 211.84(d)(6)Testing and approval or rejection of components, drug product containers, and closures2
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.137(a)Expiration dating1
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.192Production record review1
The complete Cosco International file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Marietta, Georgia
One warning letter and one Form 483 · 2024 to 2025 · 9 observations
Latest: Warning letter, Apr 14, 2025 →
Also: one document not tied to a site.
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-04-14 | Warning letter Warning letter | Marietta, Georgia | — | $99 |
| 2024-10-25 | 483 Form 483 | Marietta, Georgia | 9 | $99 |
| 2020-08-26 | Warning letter Warning letter | — | — | $99 |
Investigators on these documents
FEI number 3000220439 · most recent document Apr 14, 2025
About Cosco International, Inc.
How many FDA Form 483s has Cosco International, Inc. received?
FDA Intel has 1 Form 483 on file for Cosco International, Inc.; the most recent is dated Oct 25, 2024.
When was Cosco International, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Cosco International, Inc. is a Form 483 dated Oct 25, 2024, for the site in Marietta, Georgia.
What did FDA cite at Cosco International, Inc.?
The regulations cited most in the observations on file for Cosco International, Inc. are 21 CFR 211.84(d)(6) (Testing and approval or rejection of components, drug product containers, and closures), 2 times; 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.137(a) (Expiration dating), 1 time.
Has Cosco International, Inc. received an FDA warning letter?
Yes. FDA Intel has 2 FDA warning letters on file for Cosco International, Inc.; the most recent is dated Apr 14, 2025.